<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01442727</url>
  </required_header>
  <id_info>
    <org_study_id>TTU-JES-1</org_study_id>
    <secondary_id>1R21CA117111-01</secondary_id>
    <secondary_id>ROG-06-098-01</secondary_id>
    <nct_id>NCT01442727</nct_id>
  </id_info>
  <brief_title>Selenium in the Treatment of Arsenic Toxicity and Cancers</brief_title>
  <acronym>SETAC</acronym>
  <official_title>Selenite in the Detoxification of Arsenic and the Prevention of Arsenical Melanosis and Cancers Amongst Bangladeshi Arsenicosis Patients: A 48-week, Randomized, Double-blinded, Placebo-controlled Phase III Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Texas Tech University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>American Cancer Society, Inc.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Texas Tech University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Context: Approximately 100 million people throughout the world consume water contaminated
      with arsenic at levels above carcinogenic thresholds, including 40 million in Bangladesh
      alone, with up to one-fourth of deaths attributed to arsenic exposure in the worst-affected
      regions. There are no proven therapies for treating chronic arsenic toxicity or for
      preventing arsenical cancers. Selenium has been known to counter arsenic toxicity in a
      variety of animal models. The investigators have recently shown in animals and humans that
      this effect is mediated by the formation of [(GS)2AsSe]- , the seleno-bis(S-glutathionyl)
      arsinium ion, which is then rapidly excreted via the hepatobiliary system. Concurrently, two
      Phase II studies in China and Bangladesh have suggested clinical benefit to selenium
      supplementation in arsenicosis patients.

      Objective: To assess whether daily selenium supplementation counters arsenic toxicity in
      patients exposed to drinking water arsenic. If proven effective, selenium supplementation
      might be safely and cost-effectively implemented in the worst-affected localities.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2006</start_date>
  <completion_date type="Actual">April 2009</completion_date>
  <primary_completion_date type="Actual">April 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>changes in arsenical melanosis</measure>
    <time_frame>0 weeks (baseline), 24 weeks, and 48 weeks (end)</time_frame>
    <description>Arsenical melanosis was recorded in 4 quadrants of each patients' torsos using the Dermlite epiluminescence microscopy system. The images were then scored in a blinded, randomized fashion by a dermatologist.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>changes in blood arsenic levels</measure>
    <time_frame>week 0, week 24 and week 48</time_frame>
    <description>The levels of arsenic in patients' blood was measured to determine whether intervention had a differential effect.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>changes in urinary arsenic levels</measure>
    <time_frame>week 0, week 24 and week 48</time_frame>
    <description>The levels of arsenic in patients' urine was measured to determine whether intervention had a differential effect.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">819</enrollment>
  <condition>Arsenical Melanosis</condition>
  <condition>Arsenical Keratosis</condition>
  <condition>Arsenical Cancers</condition>
  <condition>Arsenicosis</condition>
  <condition>Arsenic Exposure</condition>
  <condition>Arsenic Toxicity</condition>
  <condition>Arsenic Poisoning</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients who receive control (placebo)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Selenium</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients who receive treatment (selenium)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sodium selenite</intervention_name>
    <description>200 micrograms (Âµg) of selenium in the form of sodium selenite; capsule form consumed once daily with breakfast.</description>
    <arm_group_label>Selenium</arm_group_label>
    <other_name>selenium</other_name>
    <other_name>selenite</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>dicalcium phosphate capsule matching the selenium capsule in appearance; consumed once daily with breakfast</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Resident of Bangladesh in an arsenic-affected region (Chandpur)

          -  Age between 12 and 55

          -  Exposure to arsenic in home drinking water greater than 50 ug/L.

          -  Arsenical melanosis on the torso confirmed by epiluminescence microscopy

        Exclusion Criteria:

          -  Recent history or plans to consume selenium-containing supplements

          -  Anticipated change in home drinking water supply during study period
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julian E Spallholz, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Texas Tech University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paul F La Porte, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pritzker School of Medicine, The University of Chicago</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Selim Ahmed, MBBS, FCPS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Child &amp; Mother Health, Dhaka, Bangladesh</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>SETAC Trial Field Office</name>
      <address>
        <city>Kalibari town</city>
        <state>Chandpur District</state>
        <country>Bangladesh</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bangladesh</country>
  </location_countries>
  <link>
    <url>http://www.bangladesh-selenium.org</url>
    <description>SETAC trial's research consortium website</description>
  </link>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 22, 2011</study_first_submitted>
  <study_first_submitted_qc>September 27, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 28, 2011</study_first_posted>
  <last_update_submitted>October 6, 2011</last_update_submitted>
  <last_update_submitted_qc>October 6, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 7, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Texas Tech University</investigator_affiliation>
    <investigator_full_name>Julian Spallholz</investigator_full_name>
    <investigator_title>Professor of Nutrition &amp; Biochemistry, Division of Nutritional Sciences, College of Human Sciences, Texas Tech University.</investigator_title>
  </responsible_party>
  <keyword>arsenical melanosis</keyword>
  <keyword>arsenical melanoses</keyword>
  <keyword>arsenical keratosis</keyword>
  <keyword>arsenical keratoses</keyword>
  <keyword>arsenical cancer</keyword>
  <keyword>arsenic cancers</keyword>
  <keyword>arsenic</keyword>
  <keyword>arsenicosis</keyword>
  <keyword>arsenic exposure</keyword>
  <keyword>arsenic toxicity</keyword>
  <keyword>arsenic poisoning</keyword>
  <keyword>drinking water</keyword>
  <keyword>selenium</keyword>
  <keyword>selenite</keyword>
  <keyword>sodium selenite</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratosis</mesh_term>
    <mesh_term>Keratosis, Actinic</mesh_term>
    <mesh_term>Poisoning</mesh_term>
    <mesh_term>Arsenic Poisoning</mesh_term>
    <mesh_term>Melanosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Selenium</mesh_term>
    <mesh_term>Selenious Acid</mesh_term>
    <mesh_term>Sodium Selenite</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

